BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28528221)

  • 1. Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study.
    Keller RL; Feng R; DeMauro SB; Ferkol T; Hardie W; Rogers EE; Stevens TP; Voynow JA; Bellamy SL; Shaw PA; Moore PE;
    J Pediatr; 2017 Aug; 187():89-97.e3. PubMed ID: 28528221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age.
    Keller RL; Eichenwald EC; Hibbs AM; Rogers EE; Wai KC; Black DM; Ballard PL; Asselin JM; Truog WE; Merrill JD; Mammel MC; Steinhorn RH; Ryan RM; Durand DJ; Bendel CM; Bendel-Stenzel EM; Courtney SE; Dhanireddy R; Hudak ML; Koch FR; Mayock DE; McKay VJ; Helderman J; Porta NF; Wadhawan R; Palermo L; Ballard RA;
    J Pediatr; 2017 Apr; 183():19-25.e2. PubMed ID: 28100402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates.
    Isayama T; Lee SK; Yang J; Lee D; Daspal S; Dunn M; Shah PS;
    JAMA Pediatr; 2017 Mar; 171(3):271-279. PubMed ID: 28114678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine Desmosine as a Novel Biomarker for Bronchopulmonary Dysplasia and Postprematurity Respiratory Disease in Extremely Preterm or Low Birth Weight Infants.
    Hirata K; Nishikawa M; Nozaki M; Kitajima H; Yanagihara I; Wada K; Fujimura M
    Am J Perinatol; 2024 May; 41(S 01):e1030-e1036. PubMed ID: 36384237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.
    Laughon MM; Langer JC; Bose CL; Smith PB; Ambalavanan N; Kennedy KA; Stoll BJ; Buchter S; Laptook AR; Ehrenkranz RA; Cotten CM; Wilson-Costello DE; Shankaran S; Van Meurs KP; Davis AS; Gantz MG; Finer NN; Yoder BA; Faix RG; Carlo WA; Schibler KR; Newman NS; Rich W; Das A; Higgins RD; Walsh MC;
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1715-22. PubMed ID: 21471086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung function at term in extremely preterm-born infants: a regional prospective cohort study.
    Bentsen MH; Markestad T; Øymar K; Halvorsen T
    BMJ Open; 2017 Oct; 7(10):e016868. PubMed ID: 29074512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation.
    Laughon M; O'Shea MT; Allred EN; Bose C; Kuban K; Van Marter LJ; Ehrenkranz RA; Leviton A;
    Pediatrics; 2009 Aug; 124(2):637-48. PubMed ID: 19620203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns.
    Wai KC; Kohn MA; Ballard RA; Truog WE; Black DM; Asselin JM; Ballard PL; Rogers EE; Keller RL;
    J Pediatr; 2016 Oct; 177():97-102.e2. PubMed ID: 27470692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants.
    Korhonen P; Tammela O; Koivisto AM; Laippala P; Ikonen S
    Early Hum Dev; 1999 Apr; 54(3):245-58. PubMed ID: 10321791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year.
    Lagatta JM; Hysinger EB; Zaniletti I; Wymore EM; Vyas-Read S; Yallapragada S; Nelin LD; Truog WE; Padula MA; Porta NFM; Savani RC; Potoka KP; Kawut SM; DiGeronimo R; Natarajan G; Zhang H; Grover TR; Engle WA; Murthy K;
    J Pediatr; 2018 Dec; 203():218-224.e3. PubMed ID: 30172426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pulmonary score for assessing the severity of neonatal chronic lung disease.
    Madan A; Brozanski BS; Cole CH; Oden NL; Cohen G; Phelps DL
    Pediatrics; 2005 Apr; 115(4):e450-7. PubMed ID: 15805348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tidal Breathing Measurements at Discharge and Clinical Outcomes in Extremely Low Gestational Age Neonates.
    Ren CL; Feng R; Davis SD; Eichenwald E; Jobe A; Moore PE; Panitch HB; Sharp JK; Kisling J; Clem C; Kemp JS
    Ann Am Thorac Soc; 2018 Nov; 15(11):1311-1319. PubMed ID: 30088802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003.
    Kobaly K; Schluchter M; Minich N; Friedman H; Taylor HG; Wilson-Costello D; Hack M
    Pediatrics; 2008 Jan; 121(1):73-81. PubMed ID: 18166559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.
    Morrow LA; Wagner BD; Ingram DA; Poindexter BB; Schibler K; Cotten CM; Dagle J; Sontag MK; Mourani PM; Abman SH
    Am J Respir Crit Care Med; 2017 Aug; 196(3):364-374. PubMed ID: 28249118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.